From: Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment
Targets
Docking score
PDBID
MAPK1
8.4546
4ZZN
TP53
4.8124
2FEJ
AKT1
7.0058
3OCB
MYC
5.0322
5YDE
GRB2
6.0258
3KFJ
RELA
7.504
3QXY
GSK3B
8.6478
4J1R
EGFR
6.957
5D41
IKBKG
4.6891
6MI3
CTNNB1
6.048
5IVN